middle.news
OncoSil Medical Validates Manufacturing and Expands Australian Production
8:39am on Monday 13th of July, 2026 AEST
•
Healthcare
Read Story
OncoSil Medical Validates Manufacturing and Expands Australian Production
8:39am on Monday 13th of July, 2026 AEST
Key Points
Completed three manufacturing validation cycles producing 50+ OncoSil™ doses
Established dedicated Australian manufacturing with $2.1 million capital investment
Capital-efficient model enhances margin potential and supply chain control
Commercial production expected in second half of 2026 pending regulatory approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE